spacer
home > pmps > winter 2001 > pharmaceutical water storageand distribution design
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Water Storageand Distribution Design

Pharmaceutical water systems provide a vital service to any pharmaceutical manufacturing facility. The key concept of pharmaceutical water storage and distribution design is to ensure that the system does not significantly deteriorate the quality of supplied process water. The system may incorporate process changes, such as temperature and pressure, to suit the end user's requirements, but the overriding factor is to deliver water within the correct validated specifications required for the application.

The major design considerations for pharmaceutical water storage and distribution systems are the quantity and quality of water required, along with the system's installation and operating costs. To maintain water quality, the storage and distribution system should be designed to inhibit microbial growth and to minimise any outside contamination of the circulating water. The fundamental points that help meet such requirements include:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By David Forte, Process Engineer at the Water Group, Pharmatec Procip Ltd, UK

David Forte graduated from the University of Wales with an MEng (Hons) in Chemical Engineering. Whilst studying, he spent time on industrial placements with Dow Corning (South Wales) and Agip (Italy). David joined Pharmatec Procip soon after qualifying and has very quickly established himself as one of the leading process engineers within the organisation, with specialist expertise in the design of critical pure water systems. He has been responsible for the design of water systems supplied and installed within AstraZeneca, Rhodia-Chirex, GlaxoSmithKline and Boots PLC amongst others. David often presents talks at industrial seminars, including the Parenteral Society.

spacer
David Forte
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement